Anatara Lifesciences Ltd (ANR.AX)
AUD 0.05
(0.0%)
AUD 0.05
(0.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | 663.4 Thousand |
| Cost of Revenue | 748.91 Thousand | 24.76 Thousand | 24.67 Thousand | 6265.00 | 16.09 Thousand | 776.25 Thousand |
| Gross Profit | -748.91 Thousand | -24.76 Thousand | -24.67 Thousand | -6265.00 | -16.09 Thousand | -112.85 Thousand |
| Operating Expenses | 710.21 Thousand | 3.26 Million | 2.99 Million | 3.1 Million | 4.18 Million | 2.89 Million |
| Selling, General and Administrative Expenses | 1.35 Million | 1.65 Million | 2.25 Million | 2.26 Million | 2.9 Million | 3.77 Million |
| Research and Development Expenses | 748.91 Thousand | 1.6 Million | 747.18 Thousand | 840.81 Thousand | 1.28 Million | 776.25 Thousand |
| Other Expenses | -1.39 Million | 1.24 Million | 487.23 Thousand | 1.1 Million | 789.21 Thousand | 877.57 Thousand |
| Cost and Expenses | 1.45 Million | 3.28 Million | 3.02 Million | 3.11 Million | 4.2 Million | 3.67 Million |
| Operating Income | -1.45 Million | -3.28 Million | -3.02 Million | -3.11 Million | -4.2 Million | -3.01 Million |
| Interest Expense | - | 2370.00 | 3320.00 | 300.00 | - | - |
| Income Tax Expense | -626.1 Thousand | -1.21 Million | -468.51 Thousand | -1.02 Million | -659.81 Thousand | -840.93 Thousand |
| Earnings before Tax | -2.07 Million | -3.23 Million | -3 Million | -3.01 Million | -4.02 Million | -2.86 Million |
| Net Income | -1.45 Million | -2.02 Million | -2.53 Million | -1.99 Million | -3.36 Million | -2.86 Million |
| Earnings Per Share Basic | -0.01 | -0.02 | -0.03 | -0.03 | -0.06 | -0.05 |
| Earnings Per Share Diluted | -0.01 | -0.02 | -0.03 | -0.03 | -0.06 | -0.05 |
| Weighted Average Shares Outstanding | 149.61 Million | 104.3 Million | 78.21 Million | 68.95 Million | 54.61 Million | 54.33 Million |
| Weighted Average Shares Outstanding (Diluted) | 150.01 Million | 104.3 Million | 78.21 Million | 68.95 Million | 54.61 Million | 54.33 Million |
| Gross Margin | - | - | - | - | - | -0.17 |
| EBIT Margin | - | - | - | - | - | -4.50 |
| Profit Margin | - | - | - | - | - | -4.32 |
| EBITDA | -1.45 Million | -3.21 Million | -2.97 Million | -3.01 Million | -4 Million | -3.68 Million |
| Earnings Before Tax Margin | - | - | - | - | - | -4.54 |
| Breakdown | 2024 FY | 2024 Q4 | 2024 Q2 | 2023 Q4 | 2023 FY | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | -272.74 Thousand | 272.74 Thousand | -395.92 Thousand | - | 395.92 Thousand |
| Cost of Revenue | 2463.00 | 411.11 Thousand | 1788.00 | 11.87 Thousand | 24.76 Thousand | 12.89 Thousand |
| Gross Profit | -2463.00 | -683.86 Thousand | 270.96 Thousand | -407.79 Thousand | -24.76 Thousand | 383.03 Thousand |
| Operating Expenses | 2.1 Million | 92.37 Thousand | 953.85 Thousand | 1.92 Million | 3.26 Million | 1.33 Million |
| Selling, General and Administrative Expenses | - | 736.39 Thousand | 616.05 Thousand | 791.64 Thousand | - | 866.28 Thousand |
| Research and Development Expenses | - | 411.11 Thousand | 337.79 Thousand | 1.12 Million | - | 473.6 Thousand |
| Other Expenses | - | -1.05 Million | - | - | 1.24 Million | - |
| Cost and Expenses | 2.1 Million | 503.48 Thousand | 955.64 Thousand | 1.93 Million | 3.28 Million | 1.35 Million |
| Operating Income | -2.1 Million | -776.23 Thousand | -955.64 Thousand | -1.93 Million | -3.28 Million | -1.35 Million |
| Interest Expense | - | - | - | 1022.00 | 2370.00 | 1348.00 |
| Income Tax Expense | -626.1 Thousand | -371.27 Thousand | -254.82 Thousand | -843.82 Thousand | -1.21 Million | -371.32 Thousand |
| Earnings before Tax | -2.07 Million | -772.05 Thousand | -934.01 Thousand | -1.91 Million | -3.23 Million | -1.32 Million |
| Net Income | -1.45 Million | -772.05 Thousand | -679.18 Thousand | -1.06 Million | -2.02 Million | -955.71 Thousand |
| Earnings Per Share Basic | - | -0.00 | -0.01 | -0.01 | - | -0.01 |
| Earnings Per Share Diluted | - | -0.00 | -0.01 | -0.01 | - | -0.01 |
| Weighted Average Shares Outstanding | 150.01 Million | 173.37 Million | 125.64 Million | 127.74 Million | 104.3 Million | 84.01 Million |
| Weighted Average Shares Outstanding (Diluted) | 150.01 Million | 174.39 Million | 125.64 Million | 127.74 Million | 104.3 Million | 84.01 Million |
| Gross Margin | - | 2.51 | 0.99 | 1.03 | - | 0.97 |
| EBIT Margin | - | 2.84 | -3.50 | 4.85 | - | -3.38 |
| Profit Margin | - | 2.83 | -2.49 | 2.70 | - | -2.41 |
| EBITDA | - | -775.56 Thousand | -953.85 Thousand | -1.92 Million | - | -1.33 Million |
| Earnings Before Tax Margin | - | 2.85 | -3.50 | 4.88 | - | -3.42 |
0159
KITS
ABN
LQZ
DUCON
0468